Source:
The Hill
| October 6, 2022 | Julia Mueller
US purchases $290 million of drug for use in radiological and nuclear emergencies
The Department of Health and Human Services (HHS) says it has spent $290 million on a drug to treat radiation sickness in the event of a nuclear emergency.
The HHS Administration for Strategic Preparedness and Response announced in a Tuesday release that it bought the drug Nplate from Amgen USA Inc. “as part of long-standing, ongoing efforts to be better prepared to save lives following radiological and nuclear emergencies.”
……..
Viewing 1 post (of 1 total)
- Discussion
-
US purchases $290 million of drug for use in radiological and nuclear emergencies https://t.co/JZHaONzIIQ pic.twitter.com/JcQ5QGJlzD
— The Hill (@thehill) October 7, 2022
Viewing 1 post (of 1 total)
You must be logged in to reply to this topic.